The following paragraph contained an error in the original publication

Synthesis of maleimide-peptide-NH~2~

All the amino acids of the peptide sequence were subsequently coupled on a Rink amide p-methylbenzhydrylamine resin (44) (100 mg, loading: 69 mmol NH~2~/mg) following the standard procedures of solid-phase peptide synthesis (10 min treatment with 20% piperidine in *N*,*N*-dimethylformamide and reaction with 3 equivalent of Fmoc-amino acid and DCC for 1--1.5 h were used for the deprotection and coupling steps, respectively), with the addition of 3 equivalent of HOBt for the incorporation of 3-maleimidepropanoic acid, and in all couplings in the octapeptide assembly (DCC 1/4 *N*,*N*~0~-dicyclohexylcarbodiimide, HOBt 1/4 1-hydroxybenzotriazole). Cleavage and deprotection were effected by reaction with TFA/H~2~O 95:5 in the case of the dipeptides (30 min), and with a TFA/H~2~O/TIS 90:5:5 mixture (5 h) in the case of the octapeptide (TIS 1/4 triisopropylsilane). Most of the TFA was removed by bubbling N~2~ into the solution, and the resulting residue was either diluted with H~2~O and lyophilized (dipeptides) or poured onto cold ether to precipitate the target molecule (octapeptide). Crude maleimide-octapeptide was obtained after centrifugation and solvent removal. All maleimide-peptides were purified by MPLC eluting with a gradient from 0 to 100% of B (A: 0.1% TFA in H~2~O, B: \[60% (0.1% TFA in H~2~O) + 40% (0.1% TFA in ACN)\], 600 ml of each solvent).

The corrected version is as given below

Synthesis of maleimide-peptide-NH~2~

All the amino acids of the peptide sequence were subsequently coupled on a Rink amide *p*-methylbenzhydrylamine resin (44) (100 mg, loading: 0.69 µmol NH~2~/mg) following the standard procedures of solid-phase peptide synthesis (10 min treatment with 20% piperidine in *N*,*N*-dimethylformamide and reaction with 3 eq. of Fmoc-amino acid and DCC for 1--1.5 h were used for the deprotection and coupling steps, respectively), with the addition of 3 eq. of HOBt for the incorporation of 3-maleimidepropanoic acid, and in all couplings in the octapeptide assembly (DCC=*N*,*N*′-dicyclohexylcarbodiimide, HOBt=1-hydroxybenzotriazole). Cleavage and deprotection were affected by reaction with TFA/H~2~O (95:5) in the case of the dipeptides (30 min), and with a TFA/H~2~O/TIS (90:5:5) mixture (5 h) in the case of the octapeptide (TIS = triisopropylsilane). Most of the TFA was removed by bubbling N~2~ into the solution, and the resulting residue was either diluted with H~2~O and lyophilized (dipeptides) or poured onto ice-cold ether to precipitate the target molecule (octapeptide). Crude maleimide-octapeptide was obtained after centrifugation and solvent removal. All maleimide-peptides were purified by MPLC eluting with a gradient from 0 to 100% of B (A: 0.1% TFA in H~2~O; B: \[60% (0.1% TFA in H~2~O) + 40% (0.1% TFA in ACN)\]; 600 ml of each solvent).
